TR200100462T2 - Muskarinik agonistleri ve antagonistleri - Google Patents
Muskarinik agonistleri ve antagonistleriInfo
- Publication number
- TR200100462T2 TR200100462T2 TR2001/00462T TR200100462T TR200100462T2 TR 200100462 T2 TR200100462 T2 TR 200100462T2 TR 2001/00462 T TR2001/00462 T TR 2001/00462T TR 200100462 T TR200100462 T TR 200100462T TR 200100462 T2 TR200100462 T2 TR 200100462T2
- Authority
- TR
- Turkey
- Prior art keywords
- antagonists
- muscarinic agonists
- compounds
- muscarinic
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bu bulus, agrinin iyilestirilmesinde yararli olan yeni bilesikler ve bunlarin farmasötik bilesimlerini temin etmektedir. Bu bulusun bilesikleri azaadamantanlar, azanoradamantanlar ve azahomoadamantanlardir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9697798P | 1998-08-18 | 1998-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100462T2 true TR200100462T2 (tr) | 2001-09-21 |
Family
ID=22260061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00462T TR200100462T2 (tr) | 1998-08-18 | 1999-08-16 | Muskarinik agonistleri ve antagonistleri |
Country Status (30)
Country | Link |
---|---|
US (5) | US6093724A (tr) |
EP (1) | EP1112272B1 (tr) |
JP (1) | JP2002523416A (tr) |
KR (1) | KR20010072784A (tr) |
CN (1) | CN1312812A (tr) |
AR (1) | AR020199A1 (tr) |
AT (1) | ATE227724T1 (tr) |
AU (1) | AU750566B2 (tr) |
BG (1) | BG105256A (tr) |
BR (1) | BR9913072A (tr) |
CA (1) | CA2340946A1 (tr) |
CO (1) | CO5130018A1 (tr) |
DE (1) | DE69903961T2 (tr) |
EE (1) | EE200100096A (tr) |
ES (1) | ES2191455T3 (tr) |
HK (1) | HK1038918A1 (tr) |
HU (1) | HUP0103203A3 (tr) |
ID (1) | ID27544A (tr) |
IL (1) | IL141050A0 (tr) |
IS (1) | IS5827A (tr) |
NO (1) | NO20010804L (tr) |
NZ (1) | NZ509762A (tr) |
PE (1) | PE20000988A1 (tr) |
PL (1) | PL346247A1 (tr) |
RU (1) | RU2219179C2 (tr) |
SK (1) | SK1892001A3 (tr) |
TR (1) | TR200100462T2 (tr) |
WO (1) | WO2000011001A1 (tr) |
YU (1) | YU13301A (tr) |
ZA (1) | ZA200100978B (tr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK4642003A3 (en) * | 2000-10-19 | 2004-05-04 | Pfizer Prod Inc | Bridged piperazine derivatives |
GB0117950D0 (en) * | 2001-02-16 | 2001-09-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands |
WO2002094827A1 (en) * | 2001-05-23 | 2002-11-28 | Neurosearch A/S | Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
US20030064979A1 (en) * | 2001-06-29 | 2003-04-03 | Hansen Thomas Kruse | Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48 |
US6828328B1 (en) * | 2002-03-01 | 2004-12-07 | Ucb S.A. | Analgesic combination of muscarinic agonists |
US7897766B2 (en) * | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
US8076350B2 (en) | 2006-12-22 | 2011-12-13 | Abbott Laboratories | Spirocyclic azaadamantane derivatives and methods of use |
CA2679876A1 (en) | 2007-03-23 | 2008-10-02 | Abbott Laboratories | 4-substituted azaadamantane derivatives and methods of use thereof |
ES2378116T3 (es) | 2007-03-23 | 2012-04-09 | Abbott Laboratories | Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos |
PE20121066A1 (es) * | 2009-06-19 | 2012-09-13 | Abbvie Inc | Derivados de diazahomoadamantano y metodos para usarlos |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
WO2011011060A1 (en) | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
WO2012040404A1 (en) * | 2010-09-23 | 2012-03-29 | Abbott Laboratories | Monohydrate of an azaadamantane derivative |
US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
WO2019126559A1 (en) | 2017-12-20 | 2019-06-27 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
UA128017C2 (uk) | 2018-09-28 | 2024-03-13 | Каруна Тереп'Ютікс, Інк. | Композиція і спосіб лікування розладу, що послаблюється активацією мускаринових рецепторів (варіанти) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739074A (en) * | 1986-01-22 | 1988-04-19 | Pennwalt Corporation | Adamantane spiro-pyrrolidine derivatives |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
JPH06502616A (ja) * | 1990-12-21 | 1994-03-24 | メルク シヤープ エンド ドーム リミテツド | 治療用化合物 |
US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
NZ321970A (en) * | 1995-11-02 | 2000-02-28 | Neurosearch As | Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
US5914338A (en) * | 1996-04-02 | 1999-06-22 | Novo Nordisk | Heterocyclic compounds and their preparation and use |
US5952339A (en) * | 1998-04-02 | 1999-09-14 | Bencherif; Merouane | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
US5986100A (en) * | 1998-04-02 | 1999-11-16 | Crooks; Peter Anthony | Pharmaceutical compositions and methods for use |
US6057446A (en) * | 1998-04-02 | 2000-05-02 | Crooks; Peter Anthony | Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
-
1999
- 1999-08-16 CN CN99809775A patent/CN1312812A/zh active Pending
- 1999-08-16 SK SK189-2001A patent/SK1892001A3/sk unknown
- 1999-08-16 EP EP99945064A patent/EP1112272B1/en not_active Expired - Lifetime
- 1999-08-16 ID IDW20010377A patent/ID27544A/id unknown
- 1999-08-16 PL PL99346247A patent/PL346247A1/xx not_active Application Discontinuation
- 1999-08-16 YU YU13301A patent/YU13301A/sh unknown
- 1999-08-16 IL IL14105099A patent/IL141050A0/xx unknown
- 1999-08-16 DE DE69903961T patent/DE69903961T2/de not_active Expired - Fee Related
- 1999-08-16 HU HU0103203A patent/HUP0103203A3/hu unknown
- 1999-08-16 CA CA002340946A patent/CA2340946A1/en not_active Abandoned
- 1999-08-16 BR BR9913072-6A patent/BR9913072A/pt not_active IP Right Cessation
- 1999-08-16 WO PCT/US1999/018570 patent/WO2000011001A1/en not_active Application Discontinuation
- 1999-08-16 TR TR2001/00462T patent/TR200100462T2/tr unknown
- 1999-08-16 AT AT99945064T patent/ATE227724T1/de not_active IP Right Cessation
- 1999-08-16 ES ES99945064T patent/ES2191455T3/es not_active Expired - Lifetime
- 1999-08-16 RU RU2001107139/04A patent/RU2219179C2/ru not_active IP Right Cessation
- 1999-08-16 NZ NZ509762A patent/NZ509762A/xx unknown
- 1999-08-16 KR KR1020017002128A patent/KR20010072784A/ko not_active Application Discontinuation
- 1999-08-16 US US09/375,149 patent/US6093724A/en not_active Expired - Fee Related
- 1999-08-16 AU AU57758/99A patent/AU750566B2/en not_active Ceased
- 1999-08-16 JP JP2000566274A patent/JP2002523416A/ja active Pending
- 1999-08-16 EE EEP200100096A patent/EE200100096A/xx unknown
- 1999-08-17 AR ARP990104100A patent/AR020199A1/es unknown
- 1999-08-18 CO CO99052330A patent/CO5130018A1/es unknown
- 1999-08-18 PE PE1999000838A patent/PE20000988A1/es not_active Application Discontinuation
-
2000
- 2000-05-09 US US09/567,785 patent/US6251916B1/en not_active Expired - Fee Related
- 2000-10-17 US US09/690,494 patent/US6323194B1/en not_active Expired - Fee Related
-
2001
- 2001-01-26 IS IS5827A patent/IS5827A/is unknown
- 2001-02-05 ZA ZA200100978A patent/ZA200100978B/xx unknown
- 2001-02-14 BG BG105256A patent/BG105256A/xx unknown
- 2001-02-16 NO NO20010804A patent/NO20010804L/no not_active Application Discontinuation
- 2001-10-05 US US09/972,415 patent/US6423842B1/en not_active Expired - Fee Related
-
2002
- 2002-01-18 HK HK02100409.3A patent/HK1038918A1/zh unknown
- 2002-03-27 US US10/108,046 patent/US6555550B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100462T2 (tr) | Muskarinik agonistleri ve antagonistleri | |
TR200102029T2 (tr) | 1-Heterosiklil ikameli diarilaminler. | |
ATE300533T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
TR199801255T2 (tr) | Vitronektin reseptör antagonistleri. | |
TR200100267T2 (tr) | İkameli anilid bileşimleri ve yöntemler. | |
TR200101412T2 (tr) | Yeni bileşikler. | |
PT1274687E (pt) | Derivados de 1,2,3,4-tetra-hidroisoquinolina | |
ATE416772T1 (de) | Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin | |
DE50306232D1 (de) | Ampholytisches copolymer und dessen verwendung | |
DE69905170T2 (de) | Thiazolopyrimidinderivate | |
ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
TR200000015T2 (tr) | Bileşikler ve metodlar | |
DK0842934T3 (da) | 5-HT1F agonister | |
SE9702773D0 (sv) | Novel compounds | |
TR200000152T2 (tr) | Yeni bileşikler. | |
TR200000785T2 (tr) | Yeni NPY antagonistleri. | |
EA200001039A1 (ru) | Кальцилитические соединения | |
TR200200359T2 (tr) | Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması | |
SE9802937D0 (sv) | Novel compounds | |
TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
TR200101493T2 (tr) | Eletriptan hidrobromid monohidrat | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
NO20002408D0 (no) | 5-HT1F antagonister | |
EA200400670A1 (ru) | Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи |